Administration of heme arginate, but not hematin, caused anaphylactic shock [1]

American Journal of Medicine

Volumn 110, Issue 3, 2001, Pages 240-

  Daimon, Makoto ^a   Susa, Shinji ^a   Igarashi, Masahiko ^a   Kato, Takeo ^a   Kameda, Wataru ^b  

^a YAMAGATA UNIVERSITY   (Japan)

^b Nihonkai Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; GLUCOSE; HEMATIN; HEME ARGINATE; PORPHOBILINOGEN DEAMINASE;

ACUTE INTERMITTENT PORPHYRIA; ADULT; ANAPHYLACTIC SHOCK; AUTOSOMAL DOMINANT INHERITANCE; BLOOD CLOTTING; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; LETTER; PRIORITY JOURNAL; TREATMENT OUTCOME; URTICARIA;

EID: 0035865869     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(00)00720-8     Document Type: Letter

References (4)

1. The porphyrias
2. Advances in understanding and treating "the little imitator," acute porphyria
3. Hematin: Effects on hemostasis
4. Early administration of heme arginate for acute porphyric attacks